血腦障壁給藥市場：2023年至2030年給藥技術、基於用途的全球預測

預計到 2023 年，全球血腦屏障給藥市場將達到 6.6715 億美元，年複合成長率為 9.04%，預計到 2030 年將成長至驚人的 12.2438 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球血腦屏障給藥市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.跨越血腦障壁的藥物輸送的全球市場規模和預測是多少？

2.在預測期內，COVID-19對全球血腦障壁跨越藥物輸送市場的阻礙因素與影響有哪些？

3.在預測期內，全球血腦障壁藥物輸送市場需要投資哪些產品/細分市場/用途/領域？

4. 全球跨血腦障壁給藥市場的競爭策略為何？

5.全球跨血腦屏障給藥市場的技術趨勢和法律規範是什麼？

6.全球血腦障壁給藥市場主要廠商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入跨血腦障壁藥物輸送的全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 阿茲海默症等神經系統疾病的發生率增加
    • 失智症盛行率上升，主要影響老年人口
    • 長期照護患者的醫療費用增加
  • 抑制因素
    • 血腦屏障（BBB）有效限制治療藥物滲入大腦
  • 機會
    • 增加奈米技術在治療各種醫療狀況的應用
    • 不斷發展的醫療旅遊業和長期照護設施
    • 加大醫藥研發投入
  • 任務
    • 與治療藥物相關的嚴重副作用
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 跨越血腦障壁的藥物輸送市場：依藥物輸送技術分類

• 介紹
• 雙特異性抗體 RMT 方法
• 被動擴散
• 改善 BBB滲透性
• 特洛伊木馬的方法

第7章 跨越血腦障壁的藥物輸送市場：用途

• 介紹
• 阿茲海默氏症
• 腦腫瘤
• 癲癇
• 獵人症候群
• 多發性硬化症
• 帕金森氏症

第8章 北美和南美跨血腦屏障給藥市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太血腦障壁藥物輸送市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲的血腦屏障給藥市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可證和定價

The Global Drug Delivery Across Blood Brain Barrier Market is forecasted to grow significantly, with a projected USD 667.15 million in 2023 at a CAGR of 9.04% and expected to reach a staggering USD 1,224.38 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Delivery Across Blood Brain Barrier Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Delivery Across Blood Brain Barrier Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Delivery Technology, market is studied across Bispecific Antibody RMT Approach, Passive Diffusion, Permeability Increase of BBB, and Trojan Horse Approach. The Bispecific Antibody RMT Approach is projected to witness significant market share during forecast period.

Based on Application, market is studied across Alzheimer's Disease, Brain Cancer, Epilepsy, Hunter's Syndrome, Multiple Sclerosis, and Parkinson's Disease. The Alzheimer's Disease is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Delivery Across Blood Brain Barrier Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Delivery Across Blood Brain Barrier Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Delivery Across Blood Brain Barrier Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Delivery Across Blood Brain Barrier Market?

4. What is the competitive strategic window for opportunities in the Global Drug Delivery Across Blood Brain Barrier Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Delivery Across Blood Brain Barrier Market?

6. What is the market share of the leading vendors in the Global Drug Delivery Across Blood Brain Barrier Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Delivery Across Blood Brain Barrier Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Drug Delivery Across Blood Brain Barrier Market, by Drug Delivery Technology, 2022 vs 2030
• 4.3. Drug Delivery Across Blood Brain Barrier Market, by Application, 2022 vs 2030
• 4.4. Drug Delivery Across Blood Brain Barrier Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidences of neurological disorders, such as Alzheimer's disease
    • 5.1.1.2. Rising prevalence of dementia, majorly affecting the elderly population
    • 5.1.1.3. Rising healthcare expenditure for long term care patients
  • 5.1.2. Restraints
    • 5.1.2.1. Blood-brain barrier (BBB) efficiently restricts penetration of therapeutic agents to the brain
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing the use of nanotechnology in treating various medical conditions
    • 5.1.3.2. Growing medical tourism industry and long-term care facilities
    • 5.1.3.3. Growing investment in pharmaceutical research & development
  • 5.1.4. Challenges
    • 5.1.4.1. Serious side effects associated with therapeutic drugs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Drug Delivery Across Blood Brain Barrier Market, by Drug Delivery Technology

• 6.1. Introduction
• 6.2. Bispecific Antibody RMT Approach
• 6.3. Passive Diffusion
• 6.4. Permeability Increase of BBB
• 6.5. Trojan Horse Approach

7. Drug Delivery Across Blood Brain Barrier Market, by Application

• 7.1. Introduction
• 7.2. Alzheimer's Disease
• 7.3. Brain Cancer
• 7.4. Epilepsy
• 7.5. Hunter's Syndrome
• 7.6. Multiple Sclerosis
• 7.7. Parkinson's Disease

8. Americas Drug Delivery Across Blood Brain Barrier Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Drug Delivery Across Blood Brain Barrier Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Drug Delivery Across Blood Brain Barrier Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET RESEARCH PROCESS
• FIGURE 2. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2022 VS 2030
• FIGURE 3. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 5. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET DYNAMICS
• FIGURE 8. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 5. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY BISPECIFIC ANTIBODY RMT APPROACH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PASSIVE DIFFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PERMEABILITY INCREASE OF BBB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY TROJAN HORSE APPROACH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 10. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY HUNTER'S SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. CANADA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. CANADA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CHINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. CHINA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. INDIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ITALY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ITALY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. POLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. POLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. QATAR DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. QATAR DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY DRUG DELIVERY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 103. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 104. DRUG DELIVERY ACROSS BLOOD BRAIN BARRIER MARKET LICENSE & PRICING